Combined therapy with deferiprone and desferrioxamine

British Journal of Haematology

Volumn 103, Issue 2, 1998, Pages 361-364

  Wonke, B ^a   Wright, C ^b   Hoffbrand, A V ^c  

^a WHITTINGTON HOSPITAL   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Deferiprone; Desferrioxamine; Iron chelation; Thalassaemia

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; FERRITIN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; IRON CHELATION; IRON OVERLOAD; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REFRACTORY ANEMIA; SUBCUTANEOUS DRUG ADMINISTRATION; URINARY EXCRETION;

ADOLESCENT; ADULT; AGED; BETA-THALASSEMIA; BLOOD TRANSFUSION; DEFEROXAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FERRITINS; HUMANS; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; MALE; MIDDLE AGED; PYRIDONES; THALASSEMIA;

EID: 0031784438     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01002.x     Document Type: Article

References (7)

1. 1, an oral iron chelator. in transfusion-dependent thalassaemia: Indian trial. British Journal of Haematalogy, 82, 460-466.
2. Araujo, A., Kosaryan, M., MacDowell, A., Wickens, D., Puri, S., Wonke, B. & Hoffbrand, A.V. (1996) A novel delivery system for continuous desferrioxamine infusion in transfusional iron overload. British Journal of Haematology, 93, 835-837.
3. Bartlett, A.N., Hoffbrand, A.V. & Kontoghiorghes, G.J. (1990) Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1): clinical observations. British Journal of Haematology, 76. 301-304.
4. Hoffbrand, A.V. Al-Refaie, F., Davis, B., Siritanakatkul, N., Jackson, B.F.A., Cochrane, J., Prescott, E. & Wonke, B. (1998) Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients. Blood, 91, 295-300.
5. Kontoghiorghes, G.J., Aldouri, M.A., Hoffbrand, A.V., Barr, J., Wonke, B., Kourouclaris, T. & Sheppard, L. (1987a) Effective chelation of iron in β thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one. British Medical Journal. 259, 1509-1512.
6. Kontoghiorghes, G.J., Aldouri, M.A., Sheppard, L.N. & Hoffbrand, A.V (1987b) 1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for the treatment of transfusional iron overload. Lancet, i, 1294-1295.
7. Olivieri, N.F., Brittenham, G.M., Matsui, D., Berkovitch, M., Blendis, L.M., Cameron, R.G., McClelland, R.A., Lin, P.P. Templeton, D.M. & Koren, G. (1995) Iron-chelation therapy with oral deferiprone in patients with thalassemia major. New England Journal of Medicine, 332, 918-922.